Biomarin Pharmaceutical reported $183.33M in Selling and Administration Expenses for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Acadia Pharmaceuticals ACAD:US $ 81.67M 15.12M
Acceleron Pharma XLRN:US $ 45.11M 9.64M
Acorda Therapeutics ACOR:US $ 29.62M 2.74M
Agios Pharmaceuticals AGIO:US $ 27.15M 2.06M
Alexion Pharmaceuticals ALXN:US $ 342.9M 101.5M
Alnylam Pharmaceuticals ALNY:US $ 142.07M 11.75M
Amgen AMGN:US $ 1.31B 79M
Arena Pharmaceuticals ARNA:US $ 30.3M 1.63M
Bayer BAYN:GR 3.77B 19M
Biogen BIIB:US $ 654.1M 16.8M
Biomarin Pharmaceutical BMRN:US $ 183.33M 828K
Bluebird Bio BLUE:US $ 68.28M 10.3M
Gilead Sciences GILD:US $ 1.18B 173M
Gw Pharmaceuticals GWPH:US 101.05M 2.71M
Insmed INSM:US $ 60.28M 3.1M
Intercept Pharmaceuticals ICPT:US $ 53.34M 4.32M
IONIS PHARMACEUT IONS:US $ 31M 25.46M
Moderna Inc MRNA:US 168M 47M
Neurocrine Biosciences NBIX:US $ 154.6M 11.4M
Ptc Therapeutics PTCT:US $ 69.25M 374K
Puma Biotechnology PBYI:US $ 26.08M 13.33M
Regeneron Pharmaceuticals REGN:US $ 445M 30.3M
Sangamo Biosciences SGMO:US $ 14.5M 1.98M
Sarepta Therapeutics SRPT:US $ 61.13M 11.22M
Seattle Genetics SGEN:US $ 180.28M 15.15M
Ultragenyx Pharmaceutical RARE:US $ 53.88M 473K
United Therapeutics UTHR:US $ 109.1M 3.7M
Vertex Pharmaceuticals VRTX:US $ 198.19M 3.52M
YTE INCY:US $ 190.7M 21.84M